COVID-19 Impacts on Agency Interaction on Cell and Gene Therapy Products
By Niki Gallo, Associate Principal Consultant, Regulatory Affairs
Game. Set. Who’s Your Partner?
By Keri Urwin
Designing High Quality CMC Regulatory Submissions – A Systematic Approach
By Jason Birri, Associate Principal Consultant
Microbiome Therapies Beyond Fecal Microbiota Transplantation (FMT) – Challenges and Opportunities
By Anmol Grover, Senior Consultant, Strategy and Program Leadership